Status
Conditions
Treatments
About
The effect of omega 3 fatty acid on serum 25-hydroxyvitamin D levels.
Full description
No data are available on the effect of omega 3 on serum 25-hydroxyvitamin D levels in Jordanian men and women.
This study was designed to investigate whether omega 3 supplementation has a potential effect on the reducing of serum 25-hydroxyvitamin D levels.
This randomized, placebo-controlled clinical trial (RCT) was designed to evaluate 300 mg omega-3FA daily for 2 months on serum levels of 25-hydroxyvitamin D levels. This RCT will be conducted on 80 to 90 Jordanian men and women aged 22 to 66 years. Baseline and follow-up levels for 25-hydroxyvitamin D (25OHD), parathyroid hormone (PTH), calcium, phosphate, liver and kidney functions will be assayed.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Age ≥18 years old
Male and female Jordanian ASU students and employees who live in Amman.
Informed written consent from the participant prior to the start of the study.
a serum 25(OH)D concentration between 10 and 70 ng/mL.
Exclusion criteria
Any eligiable subject refuses to apply with informed written consent before the start of the study.
Men or women previously diagnosed with chronic diseases, including kidney disease or GIT problems.
Who are receiving vitamin D3 supplements (3 months before the start of the study) .
Pregnants,Breastfeeding females ,Females using hormonal contraceptives
Primary purpose
Allocation
Interventional model
Masking
80 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal